|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of Picror- rhiza kurroa extract on transplanted tumours and chemical car- cinogenesis in mice显示文摘 | Joy KL Rajeshkumar NV Kuttan G | 2000 | J Ethnopharmacol2000，71，12： | 1 |
| 2 | A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer显示文摘 | Jimeno A Rubio-Viqueira B Rajeshkumar NV | | 0，，02： | 1 |
| 3 | Effect of Picrorrhiza Kurroa extract on transplanted tumours and chemical carcinogenesis in mice显示文摘 | Joy KL Rajeshkumar NV Kullan G | 2000 | Phytotherapy Research2000，71，12： | 1 |
| 4 | Effi- cacy and pharmacodynamic effects of bosutinib ( SKI-606 ) , a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts显示文摘 | MESSERSMITH WA RAJESHKUMAR NV TAN AC | 2009 | Mol Cancer Ther2009，8，6： | 1 |
| 5 | Inhibition of chemical carci- nogenesis by berberine in rats and mice 显示文摘 | Anis KV Rajeshkumar NV Kuttan R | 2001 | J Pharm Pharmacol2001，53，5： | 1 |
| 6 | MK-1775, a potent Weel inhibitor, synergizes with gemcitabine to achieve tumor regres- sions, selectively in p53-defieient pancreatic cancer xenografts 显示文摘 | Rajeshkumar NV De Oliveira E Ottenhof N | 2011 | Clin Cancer Res2011，17，9： | 1 |
| 7 | Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts显示文摘 | MESSERSMITH WA RAJESHKUMAR NV TAN AC | 2009 | Mol Cancer Ther2009，8，6： | 1 |
| 8 | Integrated preclinical and clinical development of S-trans, trans-Farnesyhhiosalicylic Acid (FTS, Salirasib) in pancreatic cancer显示文摘 | Laheru D Shah P Rajeshkumar NV | 2012 | Invest New Drugs2012，30，6： | 1 |
| 9 | Inhibition of chemical carcinogenesis by berberine in rats and mice显示文摘 | Anis KV Rajeshkumar NV Kuttan R | 2001 | J Pharm Pharmacol2001，53，5： | 1 |
| 10 | Inhibition of chemical carcinogenesis by berberine in rats and mice显示文摘 | Anis KV Rajeshkumar NV Kuttan R | 2001 | J Pharm Pharmacol2001，53，5： | 1 |
| 11 | A pilot clinical study of treatment guided by personalized turaorgrafts in patients with advanced cancer 显示文摘 | Hidalgo M Bruckheimer E Rajeshkumar NV | 2011 | Mol Cancer Ther2011，10，8： | 1 |
| 12 | Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer显示文摘 | Rajeshkumar NV Tan AC De Oliveira E | 2009 | Clin Cancer Res2009，15，12： | 1 |
| 13 | Modulation of carcinogenic response and antioxidant enzymes of rats administered with 1,2-dimethylhydrazine by Picroliv 显示文摘 | Rajeshkumar NV Kuttan R | 2003 | Cancer Lett2003，191，2： | 1 |
| 14 | Inhibition of chemical carcinogenesis by berberine in rats and mice 显示文摘 | ANIS KV RAJESHKUMAR NV KUTTAN R | 2001 | J Pharm Pharmacol2001，53，5： | 1 |
| 15 | A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer显示文摘 | Jimeno A Rubio-Viqueira B Rajeshkumar NV | | 0，，02： | 1 |
| 16 | A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model显示文摘 | Rajeshkumar NV Rasheed ZA Garcia-Garcia E | 2010 | Mol Cancer Ther2010，9，9： | 1 |
| 17 | Modulation of carcinogenic response and antioxidant enzymes of rats administered with 1,2-dimethylhydrazine by Picroliv显示文摘 | Rajeshkumar NV Kuttan R | 2003 | Cancer Lett2003，191，2： | 1 |
| 18 | Modulation of carcinogenic response and antioxidant enzymes of rats administered with 1,2-dimethylhydrazine by Picroliv显示文摘 | Rajeshkumar NV Kuttan R | 2003 | Cancer Lett2003，191，2： | 1 |
| 19 | Inhibition of chemical carcinogenesis hy berberine in rats and mice显示文摘 | Anis KV Rajeshkumar NV Kuttan R | | 0，，5： | 1 |
| 20 | Inhibition of chemical carcinogenesis by berberine in rats and mice显示文摘 | Anis KV Rajeshkumar NV Kuttan R | 2001 | J Pharm Pharmacol2001，53，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员